Tate & Lyle plc (LON:TATE)
| Market Cap | 2.45B +3.4% |
| Revenue (ttm) | 2.01B +15.6% |
| Net Income | 97.00M -32.2% |
| EPS | 0.22 -37.1% |
| Shares Out | 442.56M |
| PE Ratio | 25.51 |
| Forward PE | 15.02 |
| Dividend | 0.20 (3.58%) |
| Ex-Dividend Date | Jun 18, 2026 |
| Volume | n/a |
| Open | 553.50 |
| Previous Close | 553.50 |
| Day's Range | 553.00 - 553.50 |
| 52-Week Range | 319.40 - 580.00 |
| Beta | 0.35 |
| Analysts | Hold |
| Price Target | 554.40 (+0.16%) |
| Earnings Date | Nov 5, 2026 |
About Tate & Lyle
Tate & Lyle plc, together with its subsidiaries, engages in the provision of ingredients and solutions to the food, beverages, and other industries in North America, Asia, Middle East, Africa, Latin America, and Europe. Its portfolio includes sweeteners, fibres, stabilisers and functional systems, hydrocolloids, and starches, proteins, and functional flours. The company’s products are used in beverages, dairy, soups, sauces and dressings, bakery and snacks, confectionery, household, clinical nutrition, industrial, meat and seafood, and personal... [Read more]
Financial Performance
In fiscal year 2026, Tate & Lyle's revenue was 2.01 billion, an increase of 15.55% compared to the previous year's 1.74 billion. Earnings were 97.00 million, a decrease of -32.17%.
Financial StatementsAnalyst Summary
According to 10 analysts, the average rating for TATE stock is "Hold." The 12-month stock price target is 554p, which is an increase of 0.16% from the latest price.
News
Tate supporters rally for brothers ahead of bail hearing in Miami
Supporters of Andrew and Tristan Tate gathered outside a Miami detention centre ahead of their bail hearing.
Ingredion (INGR) Q2 2026 Earnings Call Transcript
Tate & Lyle acquisition and Argo recovery amid tapioca cost pressures.
Tate brothers are too notorious to be flight risk, lawyers argue
The pair’s legal team want them freed on bail as they fight their removal from US to face rape and sex trafficking charges in UK.
Tate’s attorney says allegations ‘puts a target on their backs’
Tate’s attorney says allegations ‘puts a target on their backs’
AI sell-off deepens as chip stocks slump in market retreat - business live
Rolling coverage of the latest economic and financial news The rout in AI stocks also followed a report by the Information that China has begun mass production of homegrown deep ultraviolet, or DUV, c...
The Guardian view on a new director at Tate: an old institution must tackle fresh issues | Editorial
A decline in visitor numbers, staff strikes and budget cuts – Jessica Morgan faces many challenges as she takes on the biggest role in the British arts scene A lack of clear vision, low morale, dwindl...
Jessica Morgan named as new director of the Tate
The 57-year-old will succeed Maria Balshaw in the role.
Tate desperately needs a radical overhaul – but will its new director really be an agent of change?
From over-hyped shows to the woeful Turner Prize, this huge institution has been beset by problems – yet new boss Jessica Morgan seems too much like a safe pair of hands to shake things up • Jessica M...
Jessica Morgan named new Tate director – with ‘big pay cut‘ to take job
Clear frontrunner leaves lucrative role at New York’s Dia Art Foundation to join UK arts organisation at critical juncture Jessica Morgan has been confirmed as the new director of Tate, marking her re...
Tate brothers to appear in Miami court
Influencer brothers Andrew and Tristan Tate are scheduled to appear before a federal magistrate in Miami on Monday.
The Tate brothers arrested by US Marshals in Miami on UK extradition request over rape and sex trafficking charges
US Marshals arrested social media influencers Andrew and Tristan Tate in Miami Saturday on an extradition request from the United Kingdom following an investigation into sexual offenses reported by se...
Tate & Lyle downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Damian McNeela downgraded Tate & Lyle to Hold from Buy with an unchanged price target of 595 GBp. The firm cites Ingredion’s firm offer for Tate for…
Tate & Lyle downgraded to Neutral from Outperform at BNP Paribas
BNP Paribas downgraded Tate & Lyle to Neutral from Outperform with a 595 GBp price target
Tate & Lyle: From sugar barons in London's East End to US takeover
Tate & Lyle on Monday agreed to a £2.7 billion ($3.6 billion) takeover in cash from U.S.-based Ingredion , marking a new chapter for one of Britain's oldest industrial names and creating a global food...
Ingredion to Take Over Tate & Lyle in $3.6 Billion Deal
Ingredion offered the equivalent of $7.94 for each Tate & Lyle share, a 59% premium to the last closing price before takeover talks were disclosed last month.
Ingredion Announces Recommended All-Cash Acquisition of Tate & Lyle
Creates a scaled global provider of specialty ingredient solutions for a healthier, tastier and more sustainable future of food Broadens Ingredion's specialty ingredients platform across texturants, ...
UK's Tate & Lyle agrees $3.6 billion Ingredion takeover
Britain's Tate & Lyle has agreed to a £2.7 billion ($3.60 billion) offer from U.S. rival Ingredion , the companies said on Monday, creating a food and beverage ingredients major.
Tate & Lyle H2 Earnings Call Highlights
Tate & Lyle LON: TATE said its full-year results were in line with revised guidance, as muted market demand and regional weakness offset progress from the integration of CP Kelco and ongoing productiv...
Tate & Lyle Earnings Call Transcript: H2 2026
Integration of CP Kelco is complete, supporting a broader solutions offering and early signs of top-line momentum. FY results met revised guidance, with revenue and EBITDA down 3% like-for-like, and a GBP 20 million bio-gums headwind expected in FY 2027.
Tate & Lyle Annual report: H2 2026
Tate & Lyle has published its H2 2026 annual report on May 21, 2026.
Tate & Lyle Slides: H2 2026
Tate & Lyle has posted slides in relation to its H2 2026 quarterly earnings report, which was published on May 21, 2026.
Tate & Lyle Annual report: H2 2026
Tate & Lyle has published its H2 2026 annual report on May 21, 2026.
Ingredion Takeover Target Tate & Lyle Posts Fall in Profit
The British ingredients company reported lower profit for what it called a disappointing fiscal year.
Tate & Lyle downgraded to Hold from Buy at Kepler Cheuvreux
Kepler Cheuvreux downgraded Tate & Lyle to Hold from Buy with a 547 GBp price target
Ingredion confirms non-binding all-cash offer of 595p/share for Tate & Lyle
In a regulatory filing, Ingredion (INGR) issued a statement regarding a non-binding all-cash offer by the company for Tate & Lyle PLC (TATYY). “Ingredion confirms it has made a non-binding…